Daparol Tablet 5 mg contains Dapagliflozin Propanediol, a potent SGLT2 (sodium-glucose co-transporter 2) inhibitor used for the management of type 2 diabetes mellitus. Dapagliflozin helps control blood sugar levels by promoting the excretion of glucose through urine, offering an insulin-independent mechanism for glycemic control.

Daparol Tablet 5 mg is formulated for oral administration and is suitable for adults with type 2 diabetes who require improved glycemic management either as monotherapy or in combination with other antidiabetic medications. Its unique action provides not only blood glucose control but also benefits for weight management and cardiovascular health in diabetic patients.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Dapagliflozin, the active ingredient in Daparol Tablet, works through:

• Inhibition of SGLT2 in the kidneys: Dapagliflozin blocks the SGLT2 protein in the proximal renal tubules, reducing glucose reabsorption from the urine back into the bloodstream.

• Increased urinary glucose excretion: By promoting glucose elimination, blood sugar levels decrease, improving glycemic control.

• Insulin-independent action: Dapagliflozin lowers glucose without directly affecting insulin secretion, reducing the risk of hypoglycemia when used alone.

• Secondary benefits: It may promote modest weight loss through calorie loss in urine and reduce blood pressure due to osmotic diuresis.

This mechanism makes Daparol an effective and convenient option for patients struggling to achieve target blood glucose levels.

Indications

Daparol Tablet 5 mg is indicated for:

• Type 2 diabetes mellitus in adults, either as monotherapy or in combination with other antidiabetic agents (such as metformin, insulin, or DPP-4 inhibitors)

• Glycemic control improvement in patients inadequately managed with diet and exercise alone

• Adjunct therapy for patients who may benefit from weight reduction and cardiovascular risk management

It is not recommended for type 1 diabetes or patients with severe kidney impairment.

Dosage and Administration

• The usual starting dose is 5 mg once daily, taken orally with or without food.

• The tablet should be swallowed whole with water.

• Depending on clinical response, the dose may be increased to 10 mg once daily under medical supervision.

• Regular blood glucose monitoring is recommended to assess efficacy and adjust treatment.

• Combine with lifestyle modifications, including diet and exercise, for optimal outcomes.

Precautions and Safety Information

• Not recommended for patients with severe renal impairment, end-stage kidney disease, or type 1 diabetes.

• Monitor for signs of urinary tract infections (UTIs) or genital infections, which may occur due to increased glucose in the urine.

• Maintain proper hydration to reduce the risk of hypotension or dehydration-related complications.

• Use caution in patients on diuretics, blood pressure medications, or with a history of recurrent infections.

• Inform your doctor about any other medications to prevent interactions.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Urinary tract infections or genital yeast infections

• Increased urination or mild dehydration

• Dizziness or lightheadedness due to fluid loss

• Nausea or abdominal discomfort

• Rarely, ketoacidosis or severe hypoglycemia when combined with insulin or sulfonylureas

Most side effects are mild and manageable with proper medical guidance.

Storage Instructions

Store Daparol Tablet 5 mg in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Daparol Tablet 5 mg provides effective, insulin-independent blood sugar control for adults with type 2 diabetes, supporting glycemic management, weight control, and overall metabolic health.